Medimmune FluMist Indication Could Exclude Patients With Asthma

MedImmune could carve out a subpopulation of FluMist patients who suffer from wheezing and asthma from the proposed indication for the intranasal vaccine, the company said following receipt of a complete response letter from FDA

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet